查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1450968

2024-2032 年按手术类型、产品、应用、指导技术、最终用户和地区分類的活检设备市场报告

Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2023年全球切片设备市场规模达26亿美元。展望未来， IMARC Group预计到2032年市场规模将达到44亿美元，2024-2032年复合年增长率（CAGR）为5.8%。癌症盛行率的上升、对个人化医疗的日益偏好，以及为了患者舒适度和更快恢復时间而推动的微创手术是推动市场的一些主要因素。

活检设备是专门设计用于从患者体内提取组织样本以进行诊断目的的医疗仪器。它们广泛用于各种医疗保健环境，有助于诊断多种疾病，包括癌症、感染和发炎性疾病。它们有不同的类型，例如针、镊子和真空辅助活检装置，每种装置都符合特定的医疗要求。透过采用超音波、CT 扫描或 MRI 等即时影像技术，医疗保健专业人员可以找出需要收集组织的确切位置，从而提高手术的成功率。因此，活检设备作为现代诊断医学中不可或缺的工具获得了巨大的关注，有助于精确和及时的干预。

人口老化更容易患上需要活检诊断的疾病，这将在预测期内刺激市场成长。此外，对个人化医疗的高度关注通常需要多次活检程序来监测疾病的进展并相应地调整治疗计划，这增加了活检设备的使用频率。与此一致的是，为了患者舒适度和更快的恢復时间，全球都在推动微创手术，这加速了专为这些侵入性较小的技术设计的活检设备的采用。此外，一些国家不断增长的医疗保健支出和支持性报销政策也促进了市场成长。由于全球政府和私人保险公司的目标是提供更好的医疗保健服务，因此活检等诊断程序获得报销的可能性更高，使患者更容易获得这些服务，从而推动市场成长。

活检设备市场趋势/驱动因素：

癌症发生率上升

全球癌症负担日益增加是活检设备市场的重要驱动力。癌症诊断需要精确的早期识别以实现最佳治疗，这使得活检成为重要的诊断工具。据世界卫生组织称，癌症是全球第二大死亡原因，2018 年估计有 960 万人死亡。随着癌症发病率持续上升，对准确、高效的诊断方法的需求也随之增加。因此，活检设备在识别恶性组织方面变得至关重要，使临床医生能够制定适当的治疗计划。癌症发生率的上升刺激了对先进活检设备的需求，从而对市场成长产生积极影响。

科技的快速进步

活检设备的创新是另一个主要的成长诱导因素。技术进步正在提高活检程序的功效、速度和安全性。例如，真空辅助活检设备可以更快、更舒适地提取组织样本，从而改善患者体验。此外，超音波、CT 扫描或 MRI 等即时影像技术与活检设备的集成为医生提供了更准确的目标区域，减少了手术併发症并提高了诊断可靠性。这些技术改进有助于提高医疗保健专业人员的产品采用率，从而推动市场成长。

对医疗基础设施的广泛投资

医疗保健基础设施投资的不断增加，特别是在新兴经济体，也推动了市场的成长。公共和私人机构增加的资金促进了医疗设施的现代化，包括诊断实验室和最先进医疗设备的采购。随着全球医疗保健系统专注于提供更准确和及时的诊断，先进活检设备的结合成为一个自然的发展。这扩大了这些设备的市场，同时确保患者更广泛地获得高品质的诊断程序，从而为市场成长提供了积极的推动力。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球切片设备市场

  • 市场概况
  • 市场业绩
  • COVID 19 的影响
  • 市场预测

第 6 章：市场区隔：依程序类型

  • 手术切片
    • 市场走向
    • 市场预测
  • 针吸切片
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依产品

  • 切片引导系统
    • 市场走向
    • 市场预测
  • 针式切片枪
    • 市场走向
    • 市场预测
  • 切片针
    • 市场走向
    • 市场预测
  • 切片钳
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按应用

  • 乳腺活检
    • 市场走向
    • 市场预测
  • 肺活检
    • 市场走向
    • 市场预测
  • 大肠直肠活检
    • 市场走向
    • 市场预测
  • 摄护腺切片
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：透过指导技术

  • 超音波引导活检
    • 市场走向
    • 市场预测
  • 立体定位活检
    • 市场走向
    • 市场预测
  • MRI导引活检
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：依最终用户

  • 医院和诊所
    • 市场走向
    • 市场预测
  • 学术及研究机构
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格指标

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Argon Medical Devices
    • Becton Dickinson and Company
    • Boston Scientific Corporation
    • Cardinal Health Inc.
    • CONMED Corporation
    • Cook Group Incorporated
    • Hologic Inc.
    • INRAD Inc.
    • Medtronic plc
Product Code: SR112024A1965

The global biopsy devices market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032. The rising prevalence of cancer, increasing preference for personalized medicine, and the push toward minimally invasive procedures for patient comfort and quicker recovery times are some of the major factors propelling the market.

Biopsy devices are medical instruments specifically designed for extracting tissue samples from a patient's body for diagnostic purposes. They are widely used in various healthcare settings and are instrumental in diagnosing a wide range of conditions, including cancer, infections, and inflammatory diseases. They are available in different types, such as needle, forceps, and vacuum-assisted biopsy devices, each serving particular medical requirements. By employing real-time imaging techniques like ultrasound, CT scans, or MRI, healthcare professionals can pinpoint the exact location from which the tissue needs to be taken, thereby improving the procedure's success rate. As a result, biopsy devices have gained immense traction as indispensable tools in modern diagnostic medicine, facilitating precise and timely interventions.

The aging population, which is more susceptible to diseases requiring biopsy for diagnosis, will stimulate market growth during the forecast period. Additionally, the heightened focus on personalized medicine, which often necessitates multiple biopsy procedures to monitor the disease's progression and adapt the treatment plan accordingly, increases the frequency of biopsy device usage. In line with this, the global push toward minimally invasive procedures for patient comfort and quicker recovery times has accelerated the adoption of biopsy devices designed for these less intrusive techniques. Furthermore, the rising healthcare expenditure and supportive reimbursement policies in several countries are contributing to market growth. As governments and private insurers across the globe aim to provide better healthcare services, there is a higher likelihood of reimbursements for diagnostic procedures like biopsies, making them more accessible to patients fueling the market growth.

Biopsy Devices Market Trends/Drivers:

Rising Incidence of Cancer

The increasing burden of cancer worldwide is a significant driver for the biopsy devices market. Cancer diagnoses require precise and early-stage identification for optimal treatment, making biopsies an essential diagnostic tool. According to the World Health Organization, cancer is the second leading cause of death globally, responsible for an estimated 9.6 million deaths in 2018. As cancer rates continue to escalate, there has been a rise in the need for accurate and efficient diagnostic methods. Therefore, biopsy devices are becoming vital in identifying malignant tissues, allowing clinicians to formulate appropriate treatment plans. The rising incidence of cancer catalyzes the demand for advanced biopsy devices, thus positively influencing market growth.

Rapid Technological Advancements

Innovations in biopsy devices represent another major growth-inducing factor. Technological advancements are improving the efficacy, speed, and safety of biopsy procedures. For instance, vacuum-assisted biopsy devices allow quicker and more comfortable extraction of tissue samples, thereby enhancing patient experience. Additionally, the integration of real-time imaging techniques such as ultrasound, CT scans, or MRI with biopsy devices provides physicians with a more accurate target area, reducing procedural complications and increasing diagnostic reliability. Such technological enhancements contribute to higher product adoption rates among healthcare professionals, which in turn is propelling market growth.

Extensive Investments in Healthcare Infrastructure

The rising investments in healthcare infrastructure, especially in emerging economies, also drive the market toward growth. The increased funding by public and private agencies facilitates the modernization of medical facilities, including diagnostic labs and the acquisition of state-of-the-art medical equipment. As healthcare systems globally are focusing on delivering more accurate and timely diagnostics, the incorporation of advanced biopsy devices becomes a natural progression. This has expanded the market for these devices while ensuring broader access to high-quality diagnostic procedures for patients, thus providing a positive thrust to the market growth.

Biopsy Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global biopsy devices market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on procedure type, product, application, guidance technique, and end user.

Breakup by Procedure Type:

Surgical Biopsy

Needle Biopsy

Surgical biopsy dominates the market

The report has provided a detailed breakup and analysis of the market based on the procedure type. This includes surgical biopsy and needle biopsy. According to the report, surgical biopsy represented the largest segment.

Surgical biopsy is widely preferred among healthcare professionals for accurate and comprehensive tissue analysis due to its high diagnostic accuracy and versatility. Unlike other biopsy methods, such as needle or liquid biopsies, surgical biopsies enable the removal of an entire tumor or a larger section of tissue, providing a more comprehensive sample for analysis. This increased sample size enhances the ability of pathologists to make accurate and definitive diagnoses, particularly in complex cases where malignancy is suspected but not confirmed through less invasive methods. Additionally, surgical biopsies are often employed in locations difficult to access by needle-based techniques, such as deeper tissues or organs. Another major contributing aspect is its utility beyond diagnosis; it often serves as both a diagnostic and therapeutic procedure by allowing for the complete excision of small malignant masses. The surgical approach is also favored in cases requiring immediate intervention or when other biopsy methods have yielded inconclusive results, thus supporting the segment growth.

Breakup by Product:

Biopsy Guidance Systems

Needle Based Biopsy Guns

Biopsy Needles

Biopsy Forceps

Others

Biopsy guidance systems represent the most popular product

A detailed breakup and analysis of the market based on the product has also been provided in the report. This includes biopsy guidance systems, needle based biopsy guns, biopsy needles, biopsy forceps, and others. According to the report, biopsy guidance systems accounted for the largest market share.

Biopsy guidance systems are crucial in enhancing the accuracy and efficiency of biopsy procedures. These guidance systems often integrate with imaging technologies like ultrasound, MRI, or CT scans to provide real-time visualization of the tissue area being targeted. Such integration allows healthcare professionals to precisely locate and assess the tissue sample needed for diagnosis, thereby reducing the risk of complications and procedural errors. In a medical landscape where precision is paramount, these guidance systems offer a significant edge. Their utility is especially prominent in complex cases where the targeted tissue is located deep within the body or near critical organs, where pinpoint accuracy is essential. Moreover, guidance systems are becoming increasingly user-friendly and compatible with various types of biopsy devices, which promotes their adoption across different healthcare settings. By facilitating quicker, more accurate, and safer procedures, biopsy guidance systems are indispensable tools that clinicians rely on, which is fueling the segment growth.

Breakup by Application:

Breast Biopsy

Lung Biopsy

Colorectal Biopsy

Prostate Biopsy

Others

Breast biopsy accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the application. This includes breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and others. According to the report, breast biopsy represented the largest segment.

The main factor driving the growth of this segment is the high incidence of breast cancer globally. According to the World Cancer Research Fund, breast cancer is the most commonly occurring cancer in women and the second most common cancer overall. Early detection is critical for effective treatment, and biopsy remains one of the most reliable diagnostic methods for confirming the presence or absence of cancerous cells in breast tissue. Furthermore, advances in imaging technologies such as mammography and ultrasound have significantly improved the accuracy of breast biopsies, making it a preferred diagnostic option. Public awareness campaigns about the importance of early detection have also played a role in the frequent utilization of breast biopsy procedures. Increasingly, women are becoming proactive about their breast health, leading to more screenings and, subsequently, more biopsies to confirm or rule out malignancy. As a result, the breast biopsy segment continues to maintain its leading position in the biopsy devices market.

Breakup by Guidance Technique:

Ultrasound Guided Biopsy

Stereotactic Guided Biopsy

MRI Guided Biopsy

Others

Ultrasound guided biopsy holds the largest share in the market

A detailed breakup and analysis of the market based on the guidance technique has also been provided in the report. This includes ultrasound guided biopsy, stereotactic guided biopsy, MRI guided biopsy, and others. According to the report, ultrasound guided biopsy accounted for the largest market share.

Ultrasound-guided biopsy provides real-time imaging, allowing healthcare professionals to visualize the exact area from which the tissue sample is to be extracted. This enhances the accuracy and efficiency of the biopsy procedure. Moreover, ultrasound-guided biopsies are less invasive and generally quicker than other methods, requiring only local anesthesia. This further improves patient comfort and reduces recovery time. Compared to other imaging modalities like MRI or CT scans, ultrasound is considerably less expensive and more widely available across healthcare settings, including smaller clinics and outpatient centers. This accessibility makes it a go-to option for many physicians. Besides this, ultrasound does not involve exposure to ionizing radiation, making it a safer alternative for repeated procedures and specific patient populations, such as pregnant women. Due to these advantages-real-time imaging, cost-effectiveness, minimal invasiveness, and safety-ultrasound-guided biopsy is widely preferred, contributing to segment growth.

Breakup by End User:

Hospitals and Clinics

Academic and Research Institutes

Others

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics, academic and research institutes, and others.

Hospitals and clinics are often the first point of contact for patients requiring diagnostic procedures, including biopsies. These healthcare settings are equipped with advanced diagnostic tools and skilled professionals capable of performing a wide range of biopsy types. The growing incidence of diseases requiring biopsies, coupled with the expansion of healthcare infrastructure globally, has led to higher adoption of biopsy devices in these institutions. Moreover, hospitals often have the financial capacity to invest in the latest biopsy technologies, further augmenting the market growth.

Although smaller in market share compared to hospitals and clinics, academic and research institutes are an essential segment. These institutions primarily focus on research and development activities aimed at improving biopsy technologies or devising new diagnostic methods. They may also conduct clinical trials to evaluate the efficacy of new biopsy devices. While the volume of biopsies performed may be lower compared to hospitals, their influence on product innovation and validation is significant.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share since the region has a high prevalence of lifestyle-related diseases, including cancer, necessitating frequent utilization of biopsy procedures for diagnosis and monitoring. According to the American Cancer Society, in 2021, an estimated 1.9 million new cancer cases were diagnosed in the United States alone. In addition, North America boasts a highly developed healthcare infrastructure, including hospitals and clinics equipped with advanced diagnostic technologies, thereby facilitating the adoption of state-of-the-art biopsy devices.

Apart from this, the region has significant investments in healthcare research and development, often leading the way in medical innovation, including the development of new and more effective biopsy techniques and devices. Furthermore, there is a strong insurance framework supporting medical procedures, including biopsies, which makes these diagnostic tests more accessible to a broader population. Also, high levels of public awareness about the importance of early diagnosis and preventive healthcare catalyze the demand for diagnostic procedures such as biopsies. These combined factors position North America as the leading regional market for biopsy devices.

Competitive Landscape:

The market is experiencing steady growth as key players are actively engaged in a range of strategic activities aimed at consolidating their market position. These actions include the development of technologically advanced devices, such as vacuum-assisted and image-guided biopsy systems, to increase accuracy and patient comfort. Companies are also focusing on mergers, acquisitions, and strategic collaborations to expand their product portfolios and geographic reach. Additionally, significant investment is being made in research and development (R&D) to innovate new products and improve existing ones. Regulatory approvals and patent filings are other critical areas of focus aimed at securing exclusivity for innovative devices. Through these combined efforts, key market players are shaping the trajectory of the biopsy devices industry.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Argon Medical Devices

Becton Dickinson and Company

Boston Scientific Corporation

Cardinal Health Inc.

CONMED Corporation

Cook Group Incorporated

Hologic Inc.

INRAD Inc.

Medtronic plc

Recent Developments:

In September 2023, Boston Scientific Corporation announced the U.S. Food and Drug Administration approval for the latest-generation WATCHMAN FLX(TM) Pro Left Atrial Appendage Closure (LAAC) Device. Designed to advance further the procedural performance and safety of the WATCHMAN technology, which is indicated to reduce stroke risk in patients with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy, the device now features a polymer coating, visualization markers, and a broader size matrix to treat a wider range of patients.

In August 2022, Mammotome, an operating company of Danaher Corporation, launched the Mammotome RevolveTM EX Dual Vacuum-Assisted Breast Biopsy System. It is the first vacuum-assisted biopsy device designed specifically for the excision of benign breast lesions and is twice as fast as traditional vacuum-assisted breast biopsy systems. This device is a minimally invasive solution and enables physicians to provide better care for patients with benign lesions by avoiding the risks and trauma of an open surgical procedure and creating little to no scarring.

Key Questions Answered in This Report:

  • How has the global biopsy devices market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biopsy devices market?
  • What is the impact of each driver, restraint, and opportunity on the global biopsy devices market?
  • What are the key regional markets?
  • Which countries represent the most attractive biopsy devices market?
  • What is the breakup of the market based on the procedure type?
  • Which is the most attractive procedure type in the biopsy devices market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the biopsy devices market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biopsy devices market?
  • What is the breakup of the market based on the guidance technique?
  • Which is the most attractive guidance technique in the biopsy devices market?
  • What is the breakup of the market based on the end-user?
  • Which is the most attractive end-user in the biopsy devices market?
  • What is the competitive structure of the global biopsy devices market?
  • Who are the key players/companies in the global biopsy devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biopsy Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID 19
  • 5.4 Market Forecast

6 Market Breakup by Procedure Type

  • 6.1 Surgical Biopsy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Needle Biopsy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Biopsy Guidance Systems
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Needle Based Biopsy Guns
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biopsy Needles
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Biopsy Forceps
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Breast Biopsy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Lung Biopsy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Colorectal Biopsy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prostate Biopsy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Guidance Technique

  • 9.1 Ultrasound-guided Biopsy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Stereotactic-guided Biopsy
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 MRI-guided Biopsy
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Hospitals and Clinics
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Academic and Research Institutes
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Argon Medical Devices
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Becton Dickinson and Company
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Boston Scientific Corporation
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Cardinal Health Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 CONMED Corporation
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Cook Group Incorporated
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Hologic Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 INRAD Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Medtronic plc
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Biopsy Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Biopsy Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biopsy Devices Market: Breakup by Procedure Type (in %), 2023
  • Figure 4: Global: Biopsy Devices Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Biopsy Devices Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Biopsy Devices Market: Breakup by Guidance Technique (in %), 2023
  • Figure 7: Global: Biopsy Devices Market: Breakup by End-User (in %), 2023
  • Figure 8: Global: Biopsy Devices Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Biopsy Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Biopsy Devices (Surgical Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Biopsy Devices (Surgical Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Biopsy Devices (Needle Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Biopsy Devices (Needle Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Biopsy Devices (Biopsy Guidance Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Biopsy Devices (Biopsy Guidance Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Biopsy Devices (Needle Based Biopsy Guns) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Biopsy Devices (Needle Based Biopsy Guns) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Biopsy Devices (Biopsy Needles) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Biopsy Devices (Biopsy Needles) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Biopsy Devices (Biopsy Forceps) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Biopsy Devices (Biopsy Forceps) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Biopsy Devices (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Biopsy Devices (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Biopsy Devices (Breast Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Biopsy Devices (Breast Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Biopsy Devices (Lung Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Biopsy Devices (Lung Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Biopsy Devices (Colorectal Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Biopsy Devices (Colorectal Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Biopsy Devices (Prostate Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Biopsy Devices (Prostate Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Biopsy Devices (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Biopsy Devices (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Biopsy Devices (Ultrasound-guided Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Biopsy Devices (Ultrasound-guided Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Biopsy Devices (Stereotactic-guided Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Biopsy Devices (Stereotactic-guided Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Biopsy Devices (MRI-guided Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Biopsy Devices (MRI-guided Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Biopsy Devices (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Biopsy Devices (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Biopsy Devices (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Biopsy Devices (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Biopsy Devices (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Biopsy Devices (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Biopsy Devices (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Biopsy Devices (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: North America: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: North America: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: United States: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: United States: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Canada: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Canada: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Asia Pacific: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Asia Pacific: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: China: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: China: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Japan: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Japan: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: India: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: India: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: South Korea: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: South Korea: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Australia: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Australia: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Indonesia: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Indonesia: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Europe: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Europe: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Germany: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Germany: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: France: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: France: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: United Kingdom: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: United Kingdom: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Italy: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Italy: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Spain: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Spain: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Russia: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Russia: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Latin America: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Latin America: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Brazil: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Brazil: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Mexico: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Mexico: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Others: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: Others: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Middle East and Africa: Biopsy Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 95: Middle East and Africa: Biopsy Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 96: Global: Biopsy Devices Industry: SWOT Analysis
  • Figure 97: Global: Biopsy Devices Industry: Value Chain Analysis
  • Figure 98: Global: Biopsy Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biopsy Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Biopsy Devices Market Forecast: Breakup by Procedure Type (in Million US$), 2024-2032
  • Table 3: Global: Biopsy Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Biopsy Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Biopsy Devices Market Forecast: Breakup by Guidance Technique (in Million US$), 2024-2032
  • Table 6: Global: Biopsy Devices Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 7: Global: Biopsy Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Biopsy Devices Market: Competitive Structure
  • Table 9: Global: Biopsy Devices Market: Key Players